Phenotyping airways disease: an A to E approach.

Phenotyping airways disease: an A to E approach.

The airway diseases asthma and chronic obstructive pulmonary disease (COPD) are heterogeneous conditions with overlapping pathophysiological and clinical features. It has previously been proposed that this heterogeneity may be characterized in terms of five relatively independent domains labelled fr...

Bibliografske podrobnosti
Main Authors:	Gonem, S, Raj, V, Wardlaw, A, Pavord, I, Green, R, Siddiqui, S
Format:	Journal article
Jezik:	English
Izdano:	2012

Podobne knjige/članki

Multi-dimensional phenotyping: towards a new taxonomy for airway disease.
od: Wardlaw, A, et al.
Izdano: (2005)

The A to E of airway disease.
od: Pavord, I, et al.
Izdano: (2010)

Eosinophilic phenotypes of airway disease.
od: Pavord, I
Izdano: (2013)

Chapter 11. Mast cell localization within the airway smooth muscle: Relationship to airway hyperresponsiveness and other asthma phenotypes
od: Wardlaw, A, et al.
Izdano: (2004)

Multiple inflammatory hits and the pathogenesis of severe airway disease.
od: Pavord, I, et al.
Izdano: (2006)

The significance of eosinophilic airway inflammation in asthma
od: Pavord, I, et al.
Izdano: (2002)

Airway hyperresponsiveness is dissociated from airway wall structural remodeling.
od: Siddiqui, S, et al.
Izdano: (2008)

Airway inflammation, airway responsiveness and cough before and after inhaled budesonide in patients with eosinophilic bronchitis.
od: Brightling, C, et al.
Izdano: (2000)

Prevalence of inflammatory bowel disease in patients with airways disease.
od: Raj, A, et al.
Izdano: (2008)

Complex airway disease: an approach to assessment and management.
od: Pavord, I
Izdano: (2013)

New insights into the relationship between airway inflammation and asthma.
od: Wardlaw, A, et al.
Izdano: (2002)

Airways Disease: Phenotyping Heterogeneity Using Measures of Airway Inflammation
od: Siddiqui Salman, et al.
Izdano: (2007-06-01)

Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma.
od: Kulkarni, N, et al.
Izdano: (2010)

The use of exhaled nitric oxide concentration to identify eosinophilic airway inflammation: an observational study in adults with asthma.
od: Berry, M, et al.
Izdano: (2005)

Comparison of airway immunopathology of eosinophilic bronchitis and asthma.
od: Brightling, C, et al.
Izdano: (2003)

A new approach to the classification and management of airways diseases: identification of treatable traits
od: Shrimanker, R, et al.
Izdano: (2017)

DP2 antagonism reduces airway smooth muscle mass in asthma by decreasing eosinophilia and myofibroblast recruitment
od: Saunders, R, et al.
Izdano: (2019)

Mast-cell infiltration of airway smooth muscle in asthma.
od: Brightling, C, et al.
Izdano: (2002)

Cluster analysis and clinical asthma phenotypes.
od: Haldar, P, et al.
Izdano: (2008)

Association between neutrophilic airway inflammation and airflow limitation in adults with asthma.
od: Shaw, D, et al.
Izdano: (2007)

Asthma control, airway responsiveness and airway inflammation.
od: Pavord, I
Izdano: (2009)

Biomarkers in the assessment and management of airways diseases.
od: Taylor, DR, et al.
Izdano: (2008)

Stability of inflammatory phenotypes in asthma.
od: Green, R, et al.
Izdano: (2012)

Will precision medicine become an effective tool for airway disease?
od: Shrimanker, R, et al.
Izdano: (2018)

Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial.
od: Siva, R, et al.
Izdano: (2007)

Eosinophils in asthma and other allergic diseases.
od: Wardlaw, A, et al.
Izdano: (2000)

The role of biomarkers in the management of airways disease.
od: Baines, K, et al.
Izdano: (2014)

Inflammometry to assess airway diseases.
od: Pavord, I, et al.
Izdano: (2008)

Do we really need a new classification of airway diseases?
od: Agusti, A, et al.
Izdano: (2018)

Interleukin-4 and -13 expression is co-localized to mast cells within the airway smooth muscle in asthma.
od: Brightling, C, et al.
Izdano: (2003)

Lung function decline and variable airway inflammatory pattern: longitudinal analysis of severe asthma.
od: Newby, C, et al.
Izdano: (2014)

Lung function decline and variable airway inflammatory pattern: Longitudinal analysis of severe asthma
od: Newby, C, et al.
Izdano: (2014)

Fevipiprant, a prostaglandin D2 receptor 2 antagonist, in patients with persistent eosinophilic asthma: a single-centre, randomised, double-blind, parallel-group, placebo-controlled trial
od: Gonem, S, et al.
Izdano: (2016)

Management of asthma in adults: current therapy and future directions.
od: Green, R, et al.
Izdano: (2003)

Computational Phenotyping of Obstructive Airway Diseases: A Systematic Review
od: Bashir MBA, et al.
Izdano: (2025-02-01)

Eosinophils in asthma and airway hyperresponsiveness.
od: Brightling, C, et al.
Izdano: (2004)

Qualitative analysis of high-resolution CT scans in severe asthma.
od: Gupta, S, et al.
Izdano: (2009)

Sputum induction to assess airway inflammation: is it an inflammatory stimulus?
od: Pavord, I
Izdano: (1998)

Measuring lung function in airways diseases: current and emerging techniques
od: Petousi, N, et al.
Izdano: (2019)

Non-invasive assessment of airway inflammation
od: Pavord, I, et al.
Izdano: (2009)